Clinical Research Directory

* Inclusion * Age ≥ 18 * BMI ≥ 30 kg/m2 * Male, Female, LGBT * Any ethnicity * Interested in weight loss and be open to being randomized in either a medical group visit arm or dietitian-led arm (willingly agree to sign consent form) * Currently within or be eligible to receive care at LAC-DHS and be empaneled to have a primary care provider (PCP) who can adjust their medicines including anti-hypertensive and diabetic medications if needed. * If had stopped taking weight loss medication (orlistat, lorcaserin, and phentermine/topiramate-ER, phenetermine, diethylpropion, phendimetrazine and benzphetamine) for at least 2 months prior enrollment * If had stopped taking supplements advertised to increase weight loss at least 3 months prior enrollment Females \>50 years of age and Males \>40 years of age meet inclusion criteria to participate in the sub-study that involves getting a Coronary Artery Calcium (CAC) scan done at the Lundquist Institute. Exclusion Criteria: * Age \<18 * BMI\< 30 kg/m2 * Unwilling to sing consent form * Currently participating in another obesity treatment program * Currently on a weight loss medication (orlistat, lorcaserin, and phentermine/topiramate-ER, phenetermine, diethylpropion, phendimetrazine and benzphetamine) * Currently on metformin or topiramate primarily prescribed for weight loss * Currently pregnant * Ineligible to receive care at LAC-DHS * Those with mental illness, substance abuse issues as well as other illnesses who are unable to follow directions related to the study or becomes disruptive to the overall group * Patients who have had bariatric surgery less than a year from time of enrollment Females \<50 years of age and Males \<40 years of age are not eligible to participate in the sub-study that involves getting a Coronary Artery Calcium (CAC) scan done at the Lundquist Institute.